Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys

This publication has 27 references indexed in Scilit:

• ‘Passive stabilization’ of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6‐OHDA‐lesioned rat
  Journal of Neurochemistry, 2003
• Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
  Published by Elsevier ,2003
• Relationship between the Appearance of Symptoms and the Level of Nigrostriatal Degeneration in a Progressive 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Lesioned Macaque Model of Parkinson's Disease
  Journal of Neuroscience, 2001
• Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regions
  Neuroscience, 1989
• Time Course of Adaptations in Dopamine Biosynthesis, Metabolism, and Release Following Nigrostriatal Lesions: Implications for Behavioral Recovery from Brain Injury
  Journal of Neurochemistry, 1987
• The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment
  European Journal of Pharmacology, 1986
• Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys
  Brain Research, 1986
• Partial lesions of the nigrostriatal pathway in the rat Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs
  Neuropharmacology, 1985
• Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization
  Brain Research, 1980
• Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations
  Journal of the Neurological Sciences, 1973